Ursodiol Tablet
Product Images NDC 68462-473

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 68462-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of ursodiol, showing its molecular arrangement including multiple hydroxyl groups and a carboxyl group, consistent with its steroidal bile acid composition.*

FDA Label Image

Glenmark Logo

FDA Label Image

Label 250 mg

Label for Ursodiol Tablets USP 250 mg oral tablets, distributed in a package containing 100 tablets. The label shows the NDC 68462-473-01 and is manufactured by Glenmark Pharmaceuticals Ltd. The label includes dosing recommendations and storage instructions, along with Glenmark branding and contact information.*

FDA Label Image

Label 500 mg

Label for Ursodiol Tablets USP 500 mg oral tablets by Glenmark Pharmaceuticals Inc. The label indicates a quantity of 100 tablets, prescription use only, and treatment for Primary Biliary Cirrhosis. It includes the NDC 68462-474-01 and barcode, storage instructions, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.